Mount Sinai Secures Over $4 Million Grant From National Institutes of Health to Study Alopecia Areata and Atopic Dermatitis in People With Down Syndrome

First-of-its-kind clinical trial with specific JAK inhibition will investigate the best treatment for inflammatory skin conditions in these patients